Universities & MS Centers
Independent review, investigator sponsorship, clinical expertise, trial infrastructure, and participant access.
Scientific and institutional partnerships
Partner With Us
The programs require credible institutions, investigators, manufacturers, reviewers, and strategic capital—not customers.
Collaboration priorities
Partnership is the next development stage.
CROs & Clinical Sites
Protocol operations, monitoring, controlled-substance capacity, data management, and quality.
GMP & CMC Partners
Formulation, sourcing, analytical methods, stability, packaging, accountability, and release testing.
Strategic Funding
Capital aligned to explicit milestones, scientific uncertainty, transparent governance, and staged decisions.
Expression of Interest
Tell us how your institution or expertise could advance, test, or challenge the programs.
Near-term work packages
Defined questions for qualified partners.
Each collaboration begins with a documented problem, deliverable, decision right, confidentiality level, and publication or ownership framework.
NovusClarus Source Audit
Review case records, dose history, concurrent therapies, timeline, symptom measures, imaging, and adverse events.
Combination Rationale Review
Assess the scientific and clinical basis for acetaminophen within the fixed-dose concept.
Belcopa Ethics Protocol
Develop disclosure, practitioner fidelity, comparator, debriefing, trust, and participant-protection architecture.
Regulatory Pathway
Clarify product classification, sponsor model, pre-IND questions, DEA requirements, and evidence sequence.
CMC Feasibility
Evaluate dosage form, sourcing, controls, analytical methods, stability, packaging, and GMP strategy.
Trial Design & Biostatistics
Refine component study, endpoints, estimands, sample size, missing data, monitoring, and reporting.
Engagement sequence
Structured from first contact.
Protected information is released only after relevance, credentials, conflicts, purpose, and access terms are reviewed.
Expression
Identity, institution, expertise, and contribution.
Qualification
Credentials, conflicts, relevance, and scope.
Non-confidential Review
Public science, status, questions, and fit.
NDA & Access
Controlled documents, role, expiry, and audit.
Work Package
Deliverables, milestones, budget, and decisions.
Governance
Publication, IP, conflicts, quality, and termination.
Review
Outcome, next gate, redesign, or stop.